Clinical Trials Browser

INDUSTRY × Observational × Breast Neoplasms × Clear all

NCT06856343 2026-05-26

REBECCA

Breast Neoplasms

NCT06930859 2026-05-22

ELEGANCE

Breast Neoplasms

NCT05006196 2026-05-20

IMOGEN

Active not recruiting

Breast Diseases, Breast Neoplasms

NCT07597993 2026-05-20

BEYOND

Not yet recruiting

Breast Neoplasms

NCT06927648 2026-05-19

CAPIVASERTIB REGULATORY POSTMARKETING SURVEILLANCE IN KOREA

Breast Neoplasms

NCT07347600 2026-05-18

reaINAVO

Breast Neoplasms

NCT07593196 2026-05-18

HER2-positive Metastatic Breast Cancer in Kazakhstan

Not yet recruiting

Breast Neoplasms

NCT05939128 2026-05-15

ERA

Active not recruiting

Breast Neoplasms

NCT06255041 2026-05-15

Detection of Cancer in Breath Samples by Trained Detection Dogs

BreastGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Lung Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT07038785 2026-05-15

PINK

Breast Neoplasms

NCT07070128 2026-05-13

STAR-BREAST

Breast Neoplasms

NCT07580105 2026-05-12

Clinical Study to Assess the Safety and Performance of Kenko Breast AI+ Medical Device as an Aid to Breast Cancer Diagnosis in Adult Women

Not yet recruiting

Breast Neoplasms

NCT06830720 2026-05-08

CAROLEEN

Breast Neoplasms

NCT07572162 2026-05-07

Post-market Safety Study of LUMISIGHT

Not yet recruiting

Anaphylaxis, Breast Neoplasms, Drug Hypersensitivity, Hypersensitivity

NCT06075758 2026-05-06

A Study of Ribociclib in Combination With Hormonal Therapy in HR+/HER2- Advanced or Metastatic Breast Cancer

Breast Neoplasms

NCT06905301 2026-05-05

IMPULSE

Breast Neoplasms

NCT07563595 2026-05-04

ELENI

Not yet recruiting

Breast Neoplasms

NCT05377684 2026-04-30

ROSE

Active not recruiting

Breast Neoplasms

NCT04158258 2026-04-23

A Study to Describe the Diagnosis, Anti-Cancer Treatment and Clinical Outcome in Patients With Newly Diagnosed Breast Cancer in Latin America

Active not recruiting

Breast Neoplasms

NCT06512350 2026-04-22

Identifying Patterns in the Breath of Individuals With Breast Cancer

Breast Neoplasms

NCT05153187 2026-04-21

Real-world Treatment Patterns of Endocrine Based Therapy Among Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor-2-negative (HR+/HER2-) Advanced Breast Cancer: An Analysis of Administrative Claims Data in Japan

1,170 enrolled 16 charts

Breast Neoplasms

NCT06187103 2026-04-21

Evaluation of Improved Onboard Patient Imaging

Active not recruiting

BreastGastrointestinalGynecologicHead & NeckThoracic

Breast Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Pelvic Neoplasms

NCT07541703 2026-04-21

Independent, External, Blinded Retrospective Validation of an AI-based Prognostic Assay in ER-Positive/HER2-Negative Early Breast Cancer

Active not recruiting

Breast Neoplasms

NCT02695121 2026-04-17

Cancer in Patients on Dapagliflozin and Other Antidiabetic Treatment

2,133,575 enrolled

BreastGenitourinary

Urinary Bladder Neoplasms, Breast Neoplasms

NCT07243002 2026-04-15

REPOWER

Breast Neoplasms

NCT04767594 2026-04-13

PERFORM

Active not recruiting

Breast Neoplasms

NCT05461430 2026-04-13

TraveraRTGx

BreastDermatologicEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmSarcomaThoracic

Anus Neoplasms, Appendiceal Neoplasms, Ascites, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Laryngeal Neoplasms, Lung Neoplasms, Melanoma, Mesothelioma, Mouth Neoplasms, Nasopharyngeal Neoplasms, Neoplasms, Unknown Primary, Oropharyngeal Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Penile Neoplasms, Stomach Neoplasms, Thymoma, Vulvar Neoplasms, Pleural Effusion, Malignant, Carcinoma, Neuroendocrine, Cholangiocarcinoma, Carcinoma, Small Cell, Carcinoma, Pancreatic Ductal, Gastrointestinal Stromal Tumors

NCT07512063 2026-04-13

A Study of Real-World Treatment Patterns and Outcomes Among HR+/HER2- Metastatic Breast Cancer Patients Treated With First-Line CDK4/6 Inhibitors

Breast Neoplasms

NCT05399329 2026-04-09

Study to Evaluate Real-world Effectiveness With Palbociclib Plus Endocrine Therapy as First-line/Second-line Treatment for HR+/HER2- Advanced Breast Cancer in Japan

Breast Neoplasms

NCT05478590 2026-04-03

A Study to Describe Treatment Patterns of Advanced Breast Cancer in Poland in the Real-world Data Setting

Breast Neoplasms

NCT06962969 2026-04-02

A Study to Understand the Patients Confirmed to Have Advanced or Metastatic Breast Cancer and Receiving Palbociclib Treatment Using a Real-world Database

Breast Neoplasms

NCT07476170 2026-04-02

Real-World Treatment Pattern and Clinical Outcome With Influential Factors of HR+/HER2-aBC 1L Patients in China

14,000 enrolled

Breast Neoplasms

NCT04943497 2026-04-01

PROSPERITY

Breast Neoplasms

NCT07498413 2026-04-01

ROTOR

218,677 enrolled

Breast Neoplasms, Disease Progression

NCT07505797 2026-04-01

AUDIBLE

Breast Diseases, Breast Neoplasms, Cystic Fibrosis, Fibroadenoma, Mastodynia

NCT04654208 2026-03-31

SIRI

Breast Neoplasms

NCT06827132 2026-03-23

CASCADE

Breast Neoplasms, Lung Neoplasms

NCT06417801 2026-03-19

Pangeia-2

Breast Neoplasms

NCT06428799 2026-03-18

EMBLEDDA-MMG

Breast Neoplasms

NCT06833853 2026-03-18

CTC-EXPRESS

Breast Neoplasms

NCT05662345 2026-03-17

ACT-MBC

Active not recruiting

Breast Neoplasms

NCT05697146 2026-03-16

RosaLEE

Active not recruiting

Breast Neoplasms

NCT06610539 2026-03-16

MAGProm

Breast Neoplasms

NCT05677308 2026-03-13

LYNPARZA Breast Cancer in the Adjuvant Setting Japan Post-Marketing Surveillance (PMS)

Breast Neoplasms

NCT05913440 2026-03-12

HER2-low Unresectable and/or Metastatic Breast Cancer in Russia

Breast Neoplasms

NCT07219277 2026-03-11

Clinical Validation of Early Detection Blood Test for Universal Large-scale Breast Cancer Screening

Breast Neoplasms

NCT07459062 2026-03-09

SPCTR-I

Breast Neoplasms

NCT07211178 2026-03-04

GEMINI Breast

Breast Neoplasms, Neoplasm, Residual, Triple Negative Breast Neoplasms

NCT04498481 2026-02-27

TREATMENT AND MONITORING PATTERNS AND CLINICAL OUTCOMES IN PATIENTS RECEIVING PALBOCICLIB COMBINATION TREATMENT (WITH AI OR FULVESTRANT) FOR HR+/HER2- A/MBC IN A COMMUNITY ONCOLOGY SETTING.

Breast Neoplasms

NCT05573893 2026-02-27

PROVIDENCE

Breast Neoplasms, Neoplasm Metastasis